compounded injectable semaglutide | GLP-1 Compound Semaglutide

WEIGHT-LOSS DRUGS' IMPACT ON CANCER RISK REVEALED IN NEW STUDY The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and "exacerbating mood disturbances." The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this "potential risk." But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K

View image online ( Weight loss injection Glucagon-like peptide 1 receptor agonists make up a new class of weight loss drugs expected to change the face of obesity management

Arrows added in purple to show the direction of gene changes for key enzymes involved in this pathway following melatonin treatment

We review your health history and determine whether lab testing is needed

Diabetic complications, like diabetic retinopathy, affect many people with diabetes